-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-659 in Neuroinflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-659 in Neuroinflammation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-659 in Neuroinflammation Drug Details: LP-659 is under development for the treatment of...
-
Analyst Opinions
Blockchain Disruptors in Southeast Asia’s Gaming Landscape
Blockchain Disruptors in Southeast Asia's Gaming Report Overview Blending blockchain with gaming allows startups to provide asset security and true digital ownership. It helps create player-driven ecosystems, and innovative gaming experiences by transforming the traditional gaming market and enhancing player engagement. The growth of blockchain gaming in Southeast Asia (SEA) is fueled by heightened player engagement through real asset ownership, transparent transactions, strong support from government policies, and strategic collaborations and investments. Key Countries ·      Indonesia ·      Myanmar ·      The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-352 in Tuberous Sclerosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. LP-352 in Tuberous Sclerosis Drug Details: LP-352 (AN-352) is under development for the treatment of...
-
Product Insights
Endesa Cordoba Solar PV Park
Endesa Cordoba Solar PV Park is a solar PV project located in Andalusia, Spain. The project is owned by Enel Green Power Espana SLU and is developed by Arena Power Solar 33 SLU; Enel Green Power Espana SLU. The project is at the permitting stage. Empower your strategies with our Endesa Cordoba Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within...
-
Product Insights
Capos del Condado IV Solar PV Park
Capos del Condado IV Solar PV Park is a solar PV project located in Andalusia, Spain. The project is owned and being developed by Arena Power Solar 33 SLU. The project is at the permitting stage. Empower your strategies with our Capos del Condado IV Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-352 in Tuberous Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-352 in Tuberous Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LP-352 in Tuberous SclerosisDrug Details: LP-352 (AN-352) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-352 in Lennox-Gastaut Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-352 in Lennox-Gastaut Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LP-352 in Lennox-Gastaut Syndrome Drug Details: LP-352 (AN-352) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-352 in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-352 in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LP-352 in Dravet Syndrome (Severe Myoclonic Epilepsy of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-352 in Epileptic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-352 in Epileptic Encephalopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LP-352 in Epileptic EncephalopathyDrug Details: LP-352 (AN-352) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HB-300 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.HB-300 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:HB-300 is under development for the treatment of...